129214-59-1 Usage
Description
15-Dihydroepoxy-15-lubiMin, a diterpene compound derived from the plant species Calocedrus formosana, is recognized for its potent anti-inflammatory and anticancer properties. This promising molecule has demonstrated the ability to inhibit the production of inflammatory mediators and suppress the growth of various cancer cell lines in vitro. Its mechanism of action is attributed to the targeting of specific signaling pathways that play a role in inflammation and cancer progression, positioning it as a potential candidate for the development of new pharmaceutical drugs.
Uses
Used in Pharmaceutical Development:
15-Dihydroepoxy-15-lubiMin is used as a potential therapeutic agent for the treatment of inflammatory diseases and cancer due to its anti-inflammatory and anticancer properties. It modulates the production of inflammatory mediators and targets signaling pathways involved in cancer progression, offering a new avenue for drug development in these areas.
Used in Anti-Inflammatory Applications:
In the field of anti-inflammatory treatments, 15-Dihydroepoxy-15-lubiMin is used as an anti-inflammatory agent to inhibit the production of inflammatory mediators, which can help in managing the symptoms and progression of inflammatory diseases.
Used in Anticancer Applications:
15-Dihydroepoxy-15-lubiMin is used as an anticancer agent, particularly for its ability to suppress the growth of various cancer cell lines in vitro. Its mechanism of action involves targeting specific signaling pathways that are crucial in cancer progression, making it a valuable compound in the development of cancer therapeutics.
Used in Drug Discovery Research:
In the pharmaceutical industry, 15-Dihydroepoxy-15-lubiMin is used as a lead compound in drug discovery research. Its unique properties and mechanism of action provide a foundation for further exploration and development of new drugs targeting inflammation and cancer.
As ongoing research continues, the potential applications of 15-Dihydroepoxy-15-lubiMin may expand, offering new opportunities for its use in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 129214-59-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,2,1 and 4 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 129214-59:
(8*1)+(7*2)+(6*9)+(5*2)+(4*1)+(3*4)+(2*5)+(1*9)=121
121 % 10 = 1
So 129214-59-1 is a valid CAS Registry Number.
129214-59-1Relevant articles and documents
1H NMR Study of the Stereochemistry of Lubimin and Related Vetispirane Sesquiterpenoids
Ewing, David F.,Whitehead, Ian M.,Atkinson, Anne,Threlfall, David R.
, p. 343 - 348 (2007/10/02)
The stereochemistry at C-2 and C-10 in lubimin, 15-dihydrolubimin and 3-hydroxylubimin derivatives has been investigated by 1H NMR spectroscopy.Using parent compounds and acetyl derivatives (24 compounds) definitive spectroscopic assignments have been made.Nine oxidised derivatives (2- and 3-keto functionalisation) have also been investigated.The usefulness of diagnostic features in the spectra are illustrated and the conformational homogeneity of the series verified.
